Salvati A, Melone V, Sellitto A, Rizzo F, et al. Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer. Breast Cancer Res 2022;24:52.
PMID: 35850772